Arformoterol tartrate
Modify Date: 2025-08-21 20:05:19
Arformoterol tartrate structure
|
Common Name | Arformoterol tartrate | ||
|---|---|---|---|---|
| CAS Number | 200815-49-2 | Molecular Weight | 494.492 | |
| Density | N/A | Boiling Point | 603.2ºC at 760mmHg | |
| Molecular Formula | C23H30N2O10 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of Arformoterol tartrateArformoterol tartrate is a long acting beta-adrenoceptor agonist drug indicated for the treatment of chronic obstructive pulmonary disease (COPD). It is sold by Sunovion, under the trade name Brovana, as a solution of arformoterol tartrate to be administered twice daily (morning and evening) by nebulization. It is the active (R,R)-enantiomer of formoterol and was approved by the United States Food and Drug Administration (FDA) on October 6, 2006 for the treatment of COPD. |
| Name | (2R,3R)-2,3-dihydroxybutanedioic acid,N-[2-hydroxy-5-[(1R)-1-hydroxy-2-[[(2R)-1-(4-methoxyphenyl)propan-2-yl]amino]ethyl]phenyl]formamide |
|---|---|
| Synonym | More Synonyms |
| Boiling Point | 603.2ºC at 760mmHg |
|---|---|
| Molecular Formula | C23H30N2O10 |
| Molecular Weight | 494.492 |
| Exact Mass | 494.190033 |
| PSA | 205.88000 |
| LogP | 1.20050 |
| Vapour Pressure | 2.12E-15mmHg at 25°C |
| Storage condition | 2~8℃ |
| Hazard Codes | Xi |
|---|
| UNII-5P8VJ2I235 |
| (2R,3R)-2,3-Dihydroxybutandisäure--N-{2-hydroxy-5-[(1R)-1-hydroxy-2-{[(1R)-2-(4-methoxyphenyl)-1-methylethyl]amino}ethyl]phenyl}formamid(1:1) |
| (2R,3R)-2,3-Dihydroxysuccinic acid - N-{2-hydroxy-5-[(1R)-1-hydroxy-2-{[(2R)-1-(4-methoxyphenyl)-2-propanyl]amino}ethyl]phenyl}formamide (1:1) |
| Butanedioic acid, 2,3-dihydroxy-, (2R,3R)-, compd. with formamide, N-[2-hydroxy-5-[(1R)-1-hydroxy-2-[[(1R)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]phenyl]- (1:1) |
| Brovana (TN) |
| Brovana |
| (R,R)-Arformoterol tartrate |
| acide (2R,3R)-2,3-dihydroxybutanedioïque - N-{2-hydroxy-5-[(1R)-1-hydroxy-2-{[(1R)-2-(4-méthoxyphényl)-1-méthyléthyl]amino}éthyl]phényl}formamide (1:1) |
| UNII:5P8VJ2I235 |
| (R,R)-Formoterol tartrate |
| N-{2-hydroxy-5-[(1R)-1-hydroxy-2-{[(1R)-2-(4-methoxyphenyl)-1-methylethyl]amino}ethyl]phenyl}formamide 2,3-dihydroxybutanedioate (salt) |
| Arformoterol tartrate (USAN) |
| Brovana Inhalation Solution |
| Arformoterol tartrate |